Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST
Clinical trial NCT04101851 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04101851
- Sponsor
- Toralf Reimer, MD PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2028-01-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.